Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ZEISS Meditec is a leading international medical technology company specializing in ophthalmology and microsurgery. The company provides comprehensive solutions for the diagnosis and treatment of ophthalmic diseases, including gold-standard systems for optical coherence tomography, surgical microscopes, and femtosecond lasers for refractive surgery. In the microsurgery segment, ZEISS offers advanced visualization technologies for neurosurgery, ENT, and spine procedures, enabling surgeons to perform complex operations with high precision. The company is increasingly focused on digital health through its ZEISS Medical Ecosystem, which integrates data and AI to optimize clinical workflows. Headquartered in Jena, Germany, ZEISS Meditec is a publicly traded entity and a key subsidiary of the Carl Zeiss Group.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ZEISS Meditec.